Fc-dependent expression of CD137 on human NK cells: insights into “agonistic” effects of anti-CD137 monoclonal antibodies
Wei Lin(Fujian University of Traditional Chinese Medicine), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Lieping Chen(Yale Cancer Center), Lai‐Xi Wang(University of Maryland, College Park), Erin Burch(Syngenta (United States)), Caroline Voskens(Friedrich-Alexander-Universität Erlangen-Nürnberg), Koji Tamada(Yamaguchi University), Guo‐Liang Tian(University of Maryland, Baltimore), Aaron Wood(University of Maryland, Baltimore), Xiaoyu Zhang(University of Maryland, Baltimore), Yadong Wei(University of Maryland, Baltimore), Dean L. Mann, Dan H. Schulze(University of Maryland, Baltimore), Daniel Schindler(Weizmann Institute of Science)
Cited by 116
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767